Christopher M. Stramecky, PA-C

Christopher Stramecky practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Christopher Stramecky's NPI, 1336117969, was assigned on March 9, 2006. Christopher Stramecky holds Alaska license 734.

Christopher Stramecky's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Christopher Stramecky's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Christopher Stramecky to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Stramecky practices. Vendor and product names are available with a free account.

Physician assistant is Christopher Stramecky's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Christopher Stramecky is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Christopher Stramecky's licenses on file in 2 states: Alaska and Michigan.

Dmand AI lists upper respiratory infection (URI) among the conditions Christopher Stramecky treats.

CMS data shows 39 Medicare services from Christopher Stramecky across 3 procedure codes in 2024, for 54 Medicare patients. Medicare paid $2,623 for them. Every service was in an office.

CMS counts 54 Medicare patients who saw Christopher Stramecky in 2024. The largest group is 65 to 74, with 24 patients. 74% of them have high blood pressure, and 65% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christopher Stramecky's median patient age at 53, with 63% women.

In 2024, Christopher Stramecky wrote 106 Medicare Part D claims for 63 patients. 95% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $19 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Christopher Stramecky for performance year 2024, reported as part of a group. Christopher Stramecky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.